Common use of Specimen Collection Procedures Clause in Contracts

Specimen Collection Procedures. All specimens will be collected at designated collection sites which have necessary personnel certified by the laboratory in accordance with National Institute of Drug Abuse standards. In addition, materials, equipment and supervision to provide for specimen collection, security, temporary storage facilities, and shipping or transportation to the laboratory will also comply with NIDA standards. Procedures for collecting urine specimens shall allow individual privacy unless there is reason to believe a person may alter or substitute the specimen to be provided. The following are the exclusive grounds constituting reason to believe an individual may have altered or substituted a specimen: The employee presents a specimen which falls outside normal temperature range (32.5-37.7 degrees Celsius/90.5-99.8 degrees Fahrenheit); and The person refuses to provide a measurement of oral body temperature; or Oral body temperature varies by more than 1 degree Celsius/1.8 degrees Fahrenheit from the temperature of the specimen. The last urine specimen provided by the employee was determined by the laboratory to have a specific gravity of less than 1.003 and a creatinine concentration below .2g/L; The collection site person observes conduct clearly and unequivocally indicating an attempt to substitute or adulterate the sample (e.g.: substitute urine in plain view, blue dye in the specimen presented, etc.); or The employee has previously been determined to have used a controlled substance without medical authorization and the test was being conducted under Department procedures providing for follow-up testing or after return to service. In any case where a determination is made by a collection site person to observe a specimen collection, a higher-level supervisor of the collection site person, or the supervisor, shall review and concur in such decision in advance. All direct observation shall be conducted by a person of the same gender as the person providing the specimen. In any case where collection is monitored2 by non-medical personnel, the person shall be the same gender as the person providing the specimen. The following procedures shall be used to ensure the integrity and identity of the specimen: Toilet bluing agents will be placed in the toilet tanks whenever possible so the reservoir remains blue. Where practical, there shall be no other source of water in the enclosure where urination occurs. If there is another source of water, it shall be effectively secured or monitored so as to ensure it is not used as a source for diluting the specimen. Upon arriving at the collection site, the employee to be tested shall present the collection site person with proper identification to ensure that he/she is positively identified as the person selected for testing (e.g.: by presenting a driver’s license or other photo identification). If the employee’s identity cannot be established, the supervisor will establish the employee’s identification. If requested by the employee, the collection site person shall show his or her identification to the employee. Prior to providing a sample, the employee will also be required to read and sign a consent and release form authorizing the collection for the specimen, analysis of the specimen for designated controlled substances and release of the test results to the Department Head or his/her designee or his/her designee (hereinafter referred to as the “the Department Head or his/her designee”). If the employee scheduled to be randomly tested fails to arrive at the collection site at the assigned time, the collection site person shall contact the Department Head or his/her designee to obtain guidance on the action to be taken. The employee to be tested will be required to remove any unnecessary outer garments (e.g.: coat or jacket) that might conceal items or substances that could be used to tamper with or adulterate the urine specimen. The collection site person shall ensure that all personal belongings such as purses or briefcases remain with the outer garments. The employee may retain his or her wallet. If requested, the collection site person shall provide the employee with a receipt for any personal belongings. The employee shall be instructed to wash and dry his/her hands prior to urination. After washing his/her hands, the employee shall remain in the presence of the collection site person and shall not have access to any water fountain, faucet, soap dispenser, cleaning agent or any other materials which could be used to adulterate the specimen. The employee may provide his/her specimen in the privacy of a stall or otherwise partitioned area that allows for individual privacy. The collection person shall provide the employee with a specimen bottle or collection container, as applicable. The collection site person shall note any unusual behavior or appearance of the employee which may indicate the sample may have been tampered with on the urine custody and control form. Upon receiving the specimen from the employee, the collection site person shall determine if it contains at least 60 milliliters of urine. If the employee is unable to provide 60 milliliters of urine, the collection site person shall direct the employee to drink fluids and, after a reasonable time, again attempt to provide a complete sample using a fresh specimen bottle or a fresh collection container. The original specimen shall be discarded. If the employee is still unable to provide a complete specimen, the following rules apply: In the case of a reasonable suspicion test, the employee shall remain at the collection site and continue to consume reasonable quantities of fluids until the specimen has been provided or until the expiration of a period up to eight (8) hours from the beginning of the collection procedure. If the employee cannot provide a complete sample within the up to eight (8) hour period or at the subsequent collection, as applicable, then the Medical Review Officer (MRO) shall refer the employee for a medical evaluation to develop pertinent information concerning whether the employee’s inability to provide a specimen is genuine or constitutes a refusal to provide a specimen3. The medical evaluator shall report his or her findings to the MRO. Upon completion of the examination, the MRO shall report his/her conclusions to the Department Head or his/her designee in writing. Immediately after the specimen is collected, the collection site person shall measure the temperature of the specimen. The temperature measuring device used must accurately reflect the temperature of the specimen and not contaminate the specimen. The time from urination to temperature measure is critical and in no case shall exceed for (4) minutes. A specimen temperature outside the range of 32.5-37.7 degrees Celsius/90.5-99.8 degrees Fahrenheit constitutes a reason to believe that the employee has altered or substituted the specimen in accordance with paragraph 4(b)(1) above. This may be cause for the employee to be required to provide another specimen under direct observation. In such cases, the employee supplying the specimen may volunteer to have his or her oral temperature taken to provide evidence to counter the reason to believe the employee may have altered or substituted the specimen. Immediately after the specimen is collected, the collection site person shall also inspect the specimen to determine its color and look for any signs of contaminants. Any unusual findings shall be noted on the custody and control form. All specimens suspected of being adulterated shall be forwarded to the laboratory for testing. Whenever there is reason to believe that a particular employee has altered or substituted the specimen as provided in paragraph 4(b)(1) or (3) above, a second specimen shall be obtained as soon as possible under the direct observation of a collection site person or the same gender. To the maximum extent possible, the collection site personnel shall keep the employee and the employee’s specimen bottle within sight both before and after the employee has urinated. After the specimen is collected it shall be divided into two collection bottles and it shall be properly sealed (by placement of a tamperproof seal over the bottle cap and down the sides of the bottle) and labeled in the presence of the employee. If the specimen is transferred to a second bottle, the collection site person shall request the employee to observe the transfer of the specimen and the placement of the tamperproof seal over the bottle cap and down the sides of the bottle. The collection site person, in the presence of the employee shall place securely on the bottle an identification label which contains the date, the employee’s specimen number and any other identifying information provided or required by the Department. If separate from the label, the tamperproof seal shall also be applied. The employee shall, in the presence of the collection site person, initial the identification label on the specimen bottle for the purpose of certifying that it is the specimen collected from him/her. The collection site person shall, in the presence of the employee, enter on the drug testing Custody and Control Form all information identifying the specimen. The collection site person shall sign the form certifying that the collection was accomplished according to the procedures described herein. The employee shall be asked to read and sign a statement on the drug testing Custody and Control Form certifying that the specimen identified as having been collected from him or her is in fact the specimen he or she provided. He or she will also have the opportunity to set forth on the form information concerning medications taken or administered in the past thirty (30) days. The collection site person shall complete the chain of custody portion of the drug testing Custody and Control Form to indicate receipt of the specimen from the employee and shall certify proper completion of the collection process. If the specimen is not immediately prepared for shipment, the collection person shall ensure that it is appropriately safeguarded during temporary storage. While any part of the above chain of custody procedures is being performed, the urine specimen and custody documents must remain under the control of the involved collection site person. The collection site person shall not leave the collection site in the interval between presentation of the specimen by the employee and securing of the sample with an identifying label bearing the employee’s specimen identification number and seal initialed by the employee. If it becomes necessary for the collection person to leave during this interval, the collection shall be nullified and (at the election of the Department Head or his/her designee) a new collection begun. Collection site personnel shall arrange to ship the collected specimen to the drug testing laboratory. The specimens shall be placed in shipping containers designated to minimize the possibility of damage during shipment (e.g.: specimen boxes and/or padded mailers) and those containers shall be securely sealed to eliminate the possibility of undetected tampering. On the tape sealing the container, the collection site person shall sign and enter the date the specimens were sealed in the shipping containers for shipment. The collection site person shall ensure that the chain of custody documentation is attached or enclosed in each container sealed for shipment to the drug testing laboratory. If the employee refuses to cooperate with the collection process, the collection site person shall inform the Department Head or his/her designee and shall document the non-cooperation on the drug testing Custody and Control Form. If the sample being collected from an employee in need of medical attention (e.g.: as part of a post-accident test given in an emergency medical facility), necessary medical attention shall not be delayed in order to collect the specimen.

Specimen Collection Procedures. All specimens (a) The individual to be tested shall read and sign the receipt, Chain Of Custody (COC), and consent form(s) for alcohol and drug testing and authorization for use or disclosure of medical information form. The employee shall retain a carbon copy of each form signed. (b) The site for specimen collection will be collected at designated collection sites which have all necessary personnel certified by the laboratory in accordance with National Institute of Drug Abuse standards. In additionpersonnel, materials, equipment and supervision facilities to provide for specimen collection, security, temporary storage facilities, and shipping or transportation to the laboratory lab. (c) The collection site will also comply with NIDA standards. Procedures be secure enough to prevent unauthorized access that could compromise the integrity of the collection process or the specimen. (d) The procedure for collecting urine specimens shall will allow individual privacy unless there is reason to believe a person may alter or substitute the specimen to be provided. The following are the exclusive grounds constituting reason to believe an individual may have altered or substituted a specimen: The employee presents a specimen which falls outside normal temperature range (32.5-37.7 degrees Celsius/90.5-99.8 degrees Fahrenheit); and The person refuses to provide a measurement of oral body temperature; or Oral body temperature varies by more than 1 degree Celsius/1.8 degrees Fahrenheit from the temperature of the specimen. The last urine specimen provided by the employee was determined by the laboratory to have a specific gravity of less than 1.003 and a creatinine concentration below .2g/L; The collection site person observes conduct clearly and unequivocally indicating an attempt to substitute or adulterate the sample (e.g.: substitute urine in plain view, blue dye in the specimen presented, etc.); or The employee has previously been determined to have used a controlled substance without medical authorization and the test was being conducted under Department procedures providing for follow-up testing or after return to service. In any case where a determination is made by a collection site person to observe a specimen collection, a higher-level supervisor of the collection site person, or the supervisor, shall review and concur in such decision in advance. All direct observation shall be conducted by a person of the same gender as the person providing the specimen. In any case where collection is monitored2 by non-medical personnel, the person shall be the same gender as the person providing the specimen. The following procedures shall be used to ensure the integrity and identity of the specimen: Toilet bluing agents will be placed in the toilet tanks whenever possible so the reservoir remains blue. Where practical, there shall be no other source of water in the enclosure where urination occurs. If there is another source of water, it shall be effectively secured or monitored so as to ensure it is not used as a source for diluting the specimen. Upon arriving at the collection site, the employee to be tested shall present the collection site person with proper identification to ensure that he/she is positively identified as the person selected for testing (e.g.: by presenting a driver’s license or other photo identification). If the employee’s identity cannot be established, the supervisor will establish the employee’s identification. If requested by the employee, the collection site person shall show his or her identification to the employee. Prior to providing a sample, the employee will also be required to read and sign a consent and release form authorizing the collection for the specimen, analysis of the specimen for designated controlled substances and release of the test results to the Department Head or his/her designee or his/her designee (hereinafter referred to as the “the Department Head or his/her designee”). If the employee scheduled to be randomly tested fails to arrive at the collection site at the assigned time, the collection site person shall contact the Department Head or his/her designee to obtain guidance on the action to be taken. The employee to be tested will be required to remove any unnecessary outer garments (e.g.: coat or jacket) that might conceal items or substances that could be used to tamper with or adulterate the urine specimen. The collection site person shall ensure that all personal belongings such as purses or briefcases remain with the outer garments. The employee may retain his or her wallet. If requested, the collection site person shall provide the employee with a receipt for any personal belongings. The employee shall be instructed to wash and dry his/her hands prior to urination. After washing his/her hands, the employee shall remain in the presence of the collection site person and shall not have access to any water fountain, faucet, soap dispenser, cleaning agent or any other materials which could be used to adulterate the specimen. The employee may provide his/her specimen in the privacy of a stall or otherwise partitioned area that allows for individual privacy. The collection person shall provide the employee with a specimen bottle or collection container, as applicable. The collection site person shall note any unusual behavior or appearance of the employee which may indicate the sample may have been tampered with on the urine custody and control form. Upon receiving the specimen from the employee, the collection site person shall determine if it contains at least 60 milliliters of urine. If the employee is unable to provide 60 milliliters of urine, the collection site person shall direct the employee to drink fluids and, after a reasonable time, again attempt to provide a complete sample using a fresh specimen bottle or a fresh collection container. The original specimen shall be discarded. If the employee is still unable to provide a complete specimen, the following rules apply: In the case of a reasonable suspicion test, the employee shall remain at the collection site and continue to consume reasonable quantities of fluids until the specimen has been provided or until the expiration of a period up to eight (8) hours from the beginning of the collection procedure. If the employee cannot provide a complete sample within the up to eight (8) hour period or at the subsequent collection, as applicable, then the Medical Review Officer (MRO) shall refer the employee for a medical evaluation to develop pertinent information concerning whether the employee’s inability to provide a specimen is genuine or constitutes a refusal to provide a specimen3. The medical evaluator shall report his or her findings to the MRO. Upon completion of the examination, the MRO shall report his/her conclusions to the Department Head or his/her designee in writing. Immediately after while the specimen is collected. The specimen container shall be sealed and labeled immediately within view of the individual being tested. (1) The label shall contain a unique identifying code number (i.e.: ▇▇▇▇▇▇ date of the day the specimen was collected and the Julian date of the individual’s birthday - example: collected on 6-25 [178] and birthday of 1-10 [010], gives: 178010) (i) All paper forms that leave the collection site person shall measure only bear the temperature of the specimen. unique identifying code number (ii) The temperature measuring device used must accurately reflect the temperature of the specimen and not contaminate the specimen. The time from urination to temperature measure is critical and in no case shall exceed for (4) minutes. A specimen temperature outside the range of 32.5-37.7 degrees Celsius/90.5-99.8 degrees Fahrenheit constitutes a reason to believe consent form that the employee has altered or substituted the specimen in accordance with paragraph 4(b)(1) above. This may be cause for the employee to be required to provide another specimen under direct observation. In such cases, the employee supplying the specimen may volunteer to have his or her oral temperature taken to provide evidence to counter the reason to believe the employee may have altered or substituted the specimen. Immediately after the specimen is collected, the collection site person shall also inspect the specimen to determine its color and look for any signs of contaminants. Any unusual findings shall be noted on the custody and control form. All specimens suspected of being adulterated shall be forwarded to the laboratory for testing. Whenever there is reason to believe that a particular employee has altered or substituted the specimen as provided in paragraph 4(b)(1) or (3) above, a second specimen shall be obtained as soon as possible under the direct observation of a collection site person or the same gender. To the maximum extent possible, the collection site personnel shall keep the employee and the employee’s specimen bottle within sight both before name and after the their code number is sent to employee has urinated. After the specimen is collected it health. (2) That individual shall be divided into two collection bottles and it shall be properly sealed (by placement of a tamperproof seal over the bottle cap and down the sides of the bottle) and labeled in the presence of the employee. If the specimen is transferred to a second bottle, the collection site person shall request the employee to observe the transfer of the specimen and the placement of the tamperproof seal over the bottle cap and down the sides of the bottle. The collection site person, in the presence of the employee shall place securely on the bottle an identification label which contains the date, the employee’s specimen number and any other identifying information provided or required by the Department. If separate from the label, the tamperproof seal shall also be applied. The employee shall, in the presence of the collection site person, initial acknowledge the identification label on the specimen bottle for the purpose of certifying that it is the specimen collected from him/her. The collection site person shall, in the presence of the employee, enter on the drug testing Custody and Control Form all information identifying the specimen. The collection site person shall sign the form certifying that the collection was accomplished according to the procedures described herein. The employee shall be asked to read and sign a statement on the drug testing Custody custody and Control Form control form certifying that the specimen identified as having been collected from him or her is is, in fact fact, the specimen she/he or she provided. He or she will also have the opportunity to set forth on the form information concerning medications taken or administered in the past thirty . (30e) days. The collection site person shall complete send the chain of custody portion of collected specimen and the drug testing Custody and Control Form control form(s) to indicate receipt the Hospital’s lab. Where it will be sent to the reference lab according to the COC protocol. (f) Once collection and paperwork has been completed, the employee shall be sent home, for the remainder of their shift. (1) The supervisor must make sure that the employee is provided with a safe ride home (via other person take employee home, taxi, etc.) (i) Any violation witnessed by the supervisor of the specimen from employee driving his or her self home shall be reported to the appropriate authorities for possible arrest. (g) Any additional shifts the employee is scheduled to work, if possible, are to be covered by other employees and shall certify proper completion of the collection process. If the specimen is not immediately prepared for shipment, the collection person shall ensure that it is appropriately safeguarded during temporary storage. While any part of the above chain of custody procedures is being performed, the urine specimen and custody documents must remain under the control of the involved collection site person. The collection site person shall not leave the collection site in the interval between presentation of the specimen by the employee shall remain off-duty, with pay, until the results are returned. (h) The Hospital will pay for any missed work and securing cost of outside testing if the sample with an identifying label bearing the employee’s specimen identification number and seal initialed by the employee. If it becomes necessary for the collection person to leave during this interval, the collection shall be nullified and (at the election of the Department Head or his/her designee) a new collection begun. Collection site personnel shall arrange to ship the collected specimen to the drug testing laboratory. The specimens shall be placed in shipping containers designated to minimize the possibility of damage during shipment (e.g.: specimen boxes and/or padded mailers) and those containers shall be securely sealed to eliminate the possibility of undetected tampering. On the tape sealing the container, the collection site person shall sign and enter the date the specimens were sealed in the shipping containers for shipment. The collection site person shall ensure that the chain of custody documentation is attached or enclosed in each container sealed for shipment to the drug testing laboratory. If the employee refuses to cooperate with the collection process, the collection site person shall inform the Department Head or his/her designee and shall document the non-cooperation on the drug testing Custody and Control Form. If the sample being collected from an employee in need of medical attention (e.g.: as part of a post-accident test given in an emergency medical facility), necessary medical attention shall not be delayed in order to collect the specimenresults prove negative.

Specimen Collection Procedures. a. All specimens will be collected at designated collection sites which have necessary personnel certified by the laboratory in accordance with National Institute of Drug Abuse standards. In addition, materials, equipment and supervision to provide provi de for specimen collection, security, temporary storage facilities, and shipping or transportation to the laboratory will also comply with NIDA standards. . b. Procedures for collecting urine specimens shall allow individual privacy unless there is reason to believe a person may alter or substitute the specimen to be provided. The following are the exclusive grounds constituting reason to believe an individual may have altered or substituted a specimen: : (1) The employee presents a specimen which falls outside normal temperature range (32.5-37.7 32.5 -37.7 degrees Celsius/90.5-99.8 degrees Fahrenheit); and and (a) The person refuses to provide a measurement of oral body temperature; or or (b) Oral body temperature varies by more than 1 degree Celsius/1.8 degrees Fahrenheit Fahrenhei t from the temperature of the specimen. . (2) The last urine specimen provided by the employee was determined by the laboratory to have a specific gravity of less than 1.003 and a creatinine concentration below .2g/L; ; (3) The collection site person observes conduct clearly and unequivocally indicating an attempt to substitute or adulterate the sample (e.g.: substitute urine in plain view, blue dye in the specimen presented, etc.); or or (4) The employee has previously been determined to have used a controlled contro lled substance without medical authorization and the test was being conducted under Department procedures providing for follow-up testing upon or after return to service. In any case where a determination is made by a collection site person to observe a specimen s pecimen collection, a higher-level supervisor of the collection site person, or the supervisor/superior officer, shall review and concur in such decision in advance. All direct observation shall be conducted by a person of the same gender as the person providing pr oviding the specimen. In any case where collection is monitored2 monitored1 by non-medical personnel, the person shall be the same gender as the person providing the specimen. . c. The following procedures shall be used to ensure the integrity and identity of the specimen: spe cimen: (1) Toilet bluing agents will be placed in the toilet tanks whenever possible so the reservoir remains blue. Where practical, there shall be no other source of water in the enclosure where urination occurs. If there is another source of water, it shall be effectively secured or monitored so as to ensure it is not used as a source for diluting the specimen. . (2) Upon arriving at the collection site, the employee to be tested shall present the collection site person with proper identification identificat ion to ensure that he/she is positively identified as the person selected for testing (e.g.: by presenting a driver’s 's license or other photo identification). If the employee’s 's identity cannot be established, the supervisor supervisor/superior officer will establish the employee’s 's identification. If requested by the employee, the collection site person shall show his or her identification to the employee. . (3) Prior to providing a sample, the employee will also be required to read and sign a consent and release form authorizing the collection for the specimen, analysis of the specimen for designated controlled substances and release of the test results to the Department Head or his/her designee Colonel or his/her designee (hereinafter referred to as "the “the Department Head or his/her designee”Colonel"). . (4) If the employee scheduled to be randomly tested fails to arrive at the collection site at the assigned time, the collection site person shall contact the Department Head or his/her designee Colonel to obtain guidance on the action to be taken. . (5) The employee to be tested will be required to remove any unnecessary outer garments (e.g.: a coat or jacket) that might conceal items or substances that could be used to tamper with or adulterate the urine specimen. The collection site person shall ensure that all personal belongings such as purses or briefcases remain with the th e outer garments. The employee may retain his or her wallet. If requested, the collection site person shall provide the employee with a receipt for any personal belongings. . (6) The employee shall be instructed to wash and dry his/her hands prior to urination. ▇▇▇▇ ▇▇▇▇▇. (7) After washing his/her hands, the employee shall remain in the presence of the collection site person and shall not have access to any water fountain, faucet, soap dispenser, cleaning agent or any other materials which could be used to adulterate adulterat e the specimen. . (8) The employee may provide his/her specimen in the privacy of a stall or otherwise partitioned area that allows for individual privacy. The collection person shall provide the employee with a specimen bottle or collection container, as applicable. . (9) The collection site person shall note any unusual behavior or appearance of the employee which may indicate the sample may have been tampered with on the urine custody and control form. . (10) Upon receiving the specimen from the employee, the collection site person shall determine if it contains at least 60 milliliters of urine. If the employee is unable to provide 60 milliliters of urine, the collection site person shall direct the employee to drink fluids and, after a reasonable time, again attempt to provide a complete sample using a fresh specimen bottle or a fresh collection container. The original specimen shall be discarded. If the employee is still unable to provide a complete specimen, the following rules apply: : (a) In the case of a reasonable suspicion test, the employee shall remain at the collection site and continue to consume reasonable quantities of fluids until the specimen has been provided or until the expiration of a period up to eight (8) hours from the beginning of the collection procedure. . (b) If the employee cannot provide a complete sample within the up to eight (8) hour period or at the subsequent collection, as applicable, then the Medical Review Officer (MRO) shall refer the employee for a medical evaluation to develop pertinent information concerning whether the employee’s 's inability to provide a specimen is genuine or constitutes a refusal to provide a specimen3specimen 2. The medical evaluator shall report his or her findings to the MRO. Upon completion of the examination, the MRO shall report his/her conclusions to the Department Head or his/her designee Colonel in writing. . (11) Immediately after the specimen is collected, the collection site person shall measure the temperature of the specimen. The temperature measuring device used must mus t accurately reflect the temperature of the specimen and not contaminate the specimen. The time from urination to temperature measure is critical and in no case shall exceed for four (4) minutes. . (12) A specimen temperature outside the range of 32.5-37.7 32.5 -37.7 degrees Celsius/90.5-99.8 degrees Fahrenheit constitutes a reason to believe that the employee has altered or substituted the specimen in accordance with paragraph 4(b)(1) above. This may be cause for the employee to be required to provide another specimen under direct observation. In such cases, the employee supplying the specimen may volunteer to have his or her oral temperature taken to provide evidence to counter the reason to believe the employee may have altered or substituted the specimen. . (13) Immediately after the specimen is collected, the collection site person shall also inspect the specimen to determine its color and look for any signs of contaminants. Any unusual findings shall be noted on the custody and control form. . (14) All specimens suspected of being adulterated shall be forwarded to the laboratory for testing. . (15) Whenever there is reason to believe that a particular employee has altered or substituted the specimen as provided in paragraph 4(b)(1) or (3) above, a second specimen shall shal l be obtained as soon as possible under the direct observation of a collection site person or of the same gender. . (16) To the maximum extent possible, the collection site personnel shall keep the employee and the employee’s 's specimen bottle within sight both before and after the employee has urinated. After the specimen is collected it shall be divided into two collection bottles and it shall be properly sealed (by placement of a tamperproof seal over the bottle cap and down the sides of the bottle) and labeled in the presence of the employee. If the specimen is transferred to a second bottle, the collection site person shall request the employee to observe the transfer of the specimen and the placement of the tamperproof seal over the bottle cap and down the sides of the bottle. . (17) The collection site person, in the presence of the employee employee, shall place securely on the bottle an identification label which contains the date, the employee’s 's specimen number and any other identifying information provided or required re quired by the Department. If separate from the label, the tamperproof seal shall also be applied. . (18) The employee shall, in the presence of the collection site person, initial the identification label on the specimen bottle for the purpose of certifying certifyin g that it is the specimen collected from him/her. . (19) The collection site person shall, in the presence of the employee, enter on the drug testing Custody and Control Form all information identifying the specimen. The collection site person shall sign the form certifying that the collection was accomplished according to the procedures described herein. person. (20) The employee shall be asked to read and sign a statement on the drug testing Custody and Control Form certifying that the specimen identified as having been collected from him or her is in fact the specimen he or she provided. He or she will also have the opportunity to set forth on the form information concerning medications taken or administered in the past thirty (30) days. . (21) The collection site person shall complete the chain of custody portion of the drug testing Custody and Control Form to indicate receipt of the specimen from the employee and shall certify proper completion of the collection process. If the specimen is not immediately prepared for shipment, the collection person shall ensure that it is appropriately safeguarded during temporary storage. . (22) While any part of the above chain of custody procedures is being performed, the urine specimen and custody documents must remain under the control of the involved collection site person. . (23) The collection site person shall not leave the collection site in the interval between presentation of the specimen by the employee and securing securement of the sample with an identifying label bearing the employee’s 's specimen identification number and seal initialed by the employee. If it becomes necessary for the collection person to leave during this interval, the collection shall be nullified and (at the election of the Department Head or his/her designeeColonel) a new collection begun. . (24) Collection site personnel shall arrange to ship the collected specimen to the drug testing laboratory. The specimens shall be placed in shipping containers designated to minimize the possibility of damage during shipment (e.g.: specimen boxes and/or padded mailers) and those containers shall be securely sealed to eliminate the possibility of undetected undetecte d tampering. On the tape sealing the container, the collection site person shall sign and enter the date the specimens were sealed in the shipping containers for shipment. The collection site person shall ensure that the chain of custody documentation is attached or enclosed in each container sealed for shipment to the drug testing laboratory. . (25) If the employee refuses to cooperate with the collection process, the collection site person shall inform the Department Head or his/her designee Colonel and shall document the non-cooperation non -cooperation on the drug testing Custody and Control Form. . (26) If the sample is being collected from an employee in need of medical attention (e.g.: , as part of a post-accident test given in an emergency medical facility), necessary medical attention shall not be delayed in order to collect the specimen. (27) A chain of custody form (and a laboratory internal chain of custody document, where applicable) shall be used for maintaining control and accountability of each specimen from the point of collection to final disposition of the specimen. The date and purpose shall be documented on the form each time a specimen is handled or transferred and every individual in the chain shall be identified. Every effort shall be made to minimize the number of persons handling specimens.